Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Zealand Pharma
< Previous
1
2
Next >
Zealand Pharma to highlight obesity pipeline at R&D Event on December 5
December 04, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
November 30, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Announces Financial Results for the First Nine Months of 2023
November 09, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma to participate in the Jefferies London Healthcare Conference in November 2023
November 07, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma conference call on November 9 at 2pm CET (8am ET) to present third quarter 2023 results
November 03, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma presents data for amylin analog ZP8396 at ObesityWeek
October 17, 2023
From
Zealand Pharma
Via
GlobeNewswire
Phase III studies to investigate survodutide for people living with obesity and overweight, with and without diabetes, cardiovascular disease and chronic kidney disease
October 05, 2023
From
Zealand Pharma
Via
GlobeNewswire
SAVE THE DATE: Zealand Pharma to host Obesity R&D Event in London on December 5, 2023
September 08, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma to participate in upcoming healthcare conferences in September 2023
September 07, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma announces designation of priority review by the US FDA for dasiglucagon in congenital hyperinsulinism
August 30, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Announces Financial Results for the First Half of 2023
August 17, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Hosts Conference Call on August 17 at 2pm CET (8am ET) to Present First Half 2023 Results
August 14, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
July 03, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism
June 30, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions
June 24, 2023
From
Zealand Pharma
Via
GlobeNewswire
Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)
June 23, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Announces Financial Results for the First Quarter of 2023
May 11, 2023
From
Zealand Pharma
Via
GlobeNewswire
Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people living with obesity or overweight
May 10, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Hosts Conference Call on May 11 at 2pm CET (8am ET) to Present First Quarter 2023 Results
May 04, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma to Participate in 22nd Annual Needham Virtual Healthcare Conference
April 12, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma announces completion of a directed issue and private placement of 6,578,948 million new ordinary shares raising gross proceeds of DKK 1.5 billion
March 30, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma announces directed issue and private placement of approximately 6.5 million new shares
March 30, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Announces Positive Phase 1 Clinical Results with Amylin Analogue ZP8396
March 28, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
March 09, 2023
From
Zealand Pharma
Via
GlobeNewswire
Correction: Zealand Pharma convenes its Annual General Meeting 2023
March 03, 2023
From
Zealand Pharma
Via
GlobeNewswire
Correction: Zealand Pharma Announces Full Year Results for 2022
March 02, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma convenes its Annual General Meeting 2023
March 02, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Announces Full Year Results for 2022
March 02, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma to Host Conference Call on March 2, 2023 at 2 pm CET (8 am ET) to Present Full Year Results for 2022
February 24, 2023
From
Zealand Pharma
Via
GlobeNewswire
Zealand Pharma Announces Financial Results for the First Nine Months of 2022
November 10, 2022
From
Zealand Pharma
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.